Lina Steinrud Mørch

A 2-year postdoctoral position is available in the Treatment and Cancer research group at the Danish Cancer Institute, Danish Cancer Society . The post is centered on pharmacoepidemiology and registry-based research into how medication exposure relates to cancer and other major health outcomes. The successful researcher will work across two Nordic programmes: REVEAL , which studies menopausal hormone therapy and major health outcomes, and WISE-Use , which examines the health effects of hormonal contraception. These programmes draw on nationwide health and prescription registries from four Nordic countries, creating a large comparative research environment with long-term follow-up and broad population coverage. The role involves the full research workflow, including study design, exposure assessment, data linkage, dataset preparation, statistical analyses, interpretation of findings, and scientific publication. The researcher will also collaborate with Nordic partners on harmonised analyses across cohorts and will have room to develop independent research questions within the group’s core themes. The group’s wider research portfolio focuses on the risks and benefits of medications in relation to cancer prevention, prognosis, survival, and other health outcomes. It brings together epidemiological methods, clinical knowledge, and large-scale registry data, with collaborations involving epidemiologists, statisticians, clinicians, and other research partners across Denmark and the Nordic region. Applicants will join an interdisciplinary and internationally oriented research environment with access to seminars, scientific meetings, and relevant courses, alongside close collaboration with experienced colleagues in cancer epidemiology and pharmacoepidemiology.